Accelerate Diagnostics
Cytovale Aiming to Enter Sepsis Testing Market With Rapid, Direct-From-Blood, Point-of-Care Platform
Premium
The company's core technology analyzes the mechanical properties of single cells and uses those properties to understand cell state and behavior.
CARB-X Awarding up to $578K to Accelerate Diagnostics for Fiber Optic Sepsis Testing Tech
CARB-X said its award will support the development of a compact instrument and research into the possible application of fiber optic technology to identify bacteria.
The company plans on launching two new iterations of its Pheno platforms this year, and one in late 2023.
Accelerate Diagnostics Q1 Revenues Climb 9 Percent, Miss Analyst Estimates
The company said that it added two contracted Pheno instruments and brought 12 instruments live in the US in the recently completed quarter.
In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More
News items for the in vitro diagnostics industry for the week of April 12, 2021.
Feb 4, 2021
Nov 5, 2020
Accelerate Diagnostics Q3 Revenues Up 57 Percent
Aug 6, 2020